Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally. The company offers ONPATTRO for hereditary transthyre...
Leadership
Yvonne L. Greenstreet M.B.A., M.D.
CEO & Director
Phillip A. Sharp Ph.D.Founder
Co-Founder, Member of the Scientific Advisory Board
Jeffrey V. Poulton M.B.A.
CFO & Executive VP
Bryan Andrew Supran J.D.
Chief Legal Officer
Pushkal P. Garg M.D.
Executive VP & Chief Research & Development Officer
Tolga Tanguler M.B.A.
Executive VP & Chief Commercial Officer
Timothy J. Maines
Chief Technical Operations & Quality Officer
Kevin Joseph Fitzgerald Ph.D.
Executive VP, Chief Scientific Officer and Head of Early Research & Early Development
